Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Dermatology Practical & Conceptual|December 4, 2023
Burden of Disease in the Real-Life Setting of Patients with Atopic Dermatitis: Italian Data From the MEASURE-AD StudyGiuseppe Argenziano, Santo Raffaele Mercuri, Paola Savoia, et al.
Frontiers in Public Health|September 2, 2024
Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian studyGiacomo Caldarola, Giulia Raimondi, Tonia Samela, et al.
Dermatology and Therapy|July 1, 2022
Update on the Management of Pediatric Psoriasis: An Italian ConsensusKetty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
Genes|June 26, 2025
Genetics of Darier's Disease: New Insights into Pathogenic MechanismsBarbara Moschella, Sabrina Busciglio, Enrico Ambrosini, et al.
Clinical and Experimental Dermatology|June 11, 2025
Effectiveness and Safety of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis and Previous Failures of Th2 Biologics: A Propensity Score-Matched StudyFrancesca Barei, Alessandra Chiei-Gallo, Alessandra Narcisi, et al.
Clinical and Experimental Dermatology|June 27, 2025
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World StudyFrancesca Barei, Stefano Macchi, Paolo Calzari, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week resultsBianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.
Italian Journal of Dermatology and Venereology|May 29, 2024
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patientsBianca Maria Piraccini, Luca Rapparini, Federico Quadrelli, et al.
American Journal of Clinical Dermatology|March 19, 2026
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World StudyMichela Starace, Luca Rapparini, Francesca Pampaloni, et al.
Pageof 2